Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
125.89
+0.45 (+0.36%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
69
70
Next >
2 Biotech Stocks You Can Buy and Hold for the Next Decade
November 28, 2022
These two companies are facing short-term issues that are likely to give way to long-term success.
Via
The Motley Fool
Stocks That Hit 52-Week Lows On Friday
November 25, 2022
On Friday, 68 companies reached new 52-week highs.
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
November 22, 2022
Via
Benzinga
Merck's Keytruda Phase 3 Trial Meets Primary Endpoint In Gastric Cancer Patients
November 22, 2022
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
November 19, 2022
These two rank among the 10 largest pharmaceutical companies on the planet.
Via
The Motley Fool
3 Biotech Stocks Smart Investors Should Be Buying Up Now
November 24, 2022
These three biotech stocks could be among the best ways to play this uncertain market for those looking for long-term growth.
Via
InvestorPlace
7 Stocks on the Perfect 10 List
November 23, 2022
Companies that have strong quality, value, or growth grades are the stocks to buy once markets recognize their business potential.
Via
InvestorPlace
Mirati Therapeutics Surges As Big Pharma Reportedly Preps For A Buyout Battle
November 23, 2022
There are reportedly numerous companies in the mix and they're all awaiting data next month.
Via
Investor's Business Daily
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch
November 23, 2022
Sales accelerated, again, in the third quarter. Here's what the company and analysts are watching.
Via
Investor's Business Daily
Mirati Therapeutics Garners Interest From Large Pharmas Ahead Of Much Awaited Data Next Month
November 23, 2022
Mirati Therapeutics Inc (NASDAQ: MRTX) is reportedly amid fresh takeover interest from large pharmaceutical companies ahead of updates on its drug pipeline. For some time, the cancer-focused company...
Via
Benzinga
Here's How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years
November 18, 2022
Via
Benzinga
What 13 Analyst Ratings Have To Say About Merck & Co
November 18, 2022
Via
Benzinga
10-Year Phase 3 Trial Shows CEL-SCI's Multikine immunotherapy Extends Lives In Head & Neck Cancer Patients
November 22, 2022
Via
Benzinga
First Patients Dosed in Phase I/II Trial of Enlivex's Off-the-Shelf Cell Therapy Candidate, AllocetraTM
November 22, 2022
On November 13, Enlivex (NASDAQ: ENLV) announced that the first patient has been dose
Via
Benzinga
Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
November 21, 2022
Via
Benzinga
OPEC Rumors, Energy Stocks Drag Wall Street
November 21, 2022
The Dow Jones Industrial Average and Nasdaq Composite are both down over 90 points midday, while the S&P 500 Index sits comfortably below fair value as well.
Via
Talk Markets
Merck & Co Unusual Options Activity For November 21
November 21, 2022
Someone with a lot of money to spend has taken a bearish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
November 21, 2022
During Monday's session, 50 stocks hit new 52-week highs.
Via
Benzinga
As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled
November 21, 2022
Markets sent mixed messages to start out Thanksgiving week.
Via
The Motley Fool
Why Is Imago Biosciences (IMGO) Stock Up 105% Today?
November 21, 2022
Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share.
Via
InvestorPlace
Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout
November 21, 2022
Seagen who? Merck is putting its cash to work buying a smaller biotech company.
Via
Investor's Business Daily
Cancer-Focused Imago BioSciences Shares Soar After Merck Deal
November 21, 2022
Via
Benzinga
Jim Simons 'The Man Who Solved The Market' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
November 20, 2022
Jim Simons is the founder and hedge fund manager of Renaissance Technologies, which currently has a total portfolio value north of $77 billion, per Stock Circle. This hedge fund uses a quantitative...
Via
Benzinga
The 25 Best Stocks to Buy for Retirement
November 19, 2022
It's an ideal time to look for the best retirement stocks to buy as many stocks trade at massive discounts while the market signals a bottom.
Via
InvestorPlace
3 Bargain Stocks You Can Buy Today and Hold Forever
November 18, 2022
The low price only matters if the underlying company can be rebuilt as needed.
Via
The Motley Fool
Credit Suisse Believes In This Pharma Giant's Low Risk Growth Against Uncertain Backdrop
November 18, 2022
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 18, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Upgrades
Via
Benzinga
Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial
November 17, 2022
Via
Benzinga
A Look Into Merck & Co's Debt
November 17, 2022
Over the past three months, shares of Merck & Co's Inc. (NYSE:MRK) moved higher by 13.30%. Before we understand the importance of debt, let's look at how much debt Merck & Co's has.
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.